scholarly journals Aattachment of nymphal Rhipicephalus sanguineus (Acari: Ixodidae) to a human in an urban area followed by severe adverse reaction shortly before drop-off

2009 ◽  
Vol 56 (1) ◽  
pp. 67-69 ◽  
Author(s):  
Igor Uspensky
Keyword(s):  
Adverse Reaction ◽  
Urban Area ◽  
Rhipicephalus Sanguineus ◽  
Severe Adverse Reaction

Treatment of Heparin-Induced Thrombocytopenia

2002 ◽  
Vol 36 (3) ◽  
pp. 489-503 ◽  
Author(s):  
William E Dager ◽  
Richard H White
Keyword(s):  
Adverse Reaction ◽  
Treatment Options ◽  
Clinical Manifestations ◽  
Low Molecular Weight ◽  
National Library ◽  
Severe Adverse Reaction ◽  
Heparin Induced Thrombocytopenia ◽  
Immune Mediated ◽  
Study Selection ◽  
Clinical Conditions

OBJECTIVE: To describe heparin-induced thrombocytopenia (HIT or HIT-2), an immune-mediated adverse reaction to heparin or low-molecular-weight heparin. Available treatment options and considerations in developing a therapy approach are discussed. DATA SOURCES: A search of the National Library of Medicine (1992–June 2001) was done to identify pertinent literature. Additional references were reviewed from selected articles. STUDY SELECTION: Articles related to laboratory recognition and treatment options of HIT, including the use of agents in selected clinical conditions, were reviewed and included. CONCLUSIONS: HIT is a rare but potentially severe adverse reaction to heparin that was, until recently, poorly understood and had limited treatment options. Recent advances describing the recognition and clinical manifestations of immune-mediated HIT, including recently available antithrombotic treatment options, have dramatically changed outcomes for patients having this syndrome.

Case report: Severe adverse reaction to oral Iohexol

1991 ◽  
Vol 44 (2) ◽  
pp. 137-138 ◽  
Author(s):  
J.R. Glover ◽  
B.M. Thomas
Keyword(s):  
Adverse Reaction ◽  
Case Report ◽  
Severe Adverse Reaction

scholarly journals The Severe Adverse Reaction to Vitamin K1 Injection Is Anaphylactoid Reaction but Not Anaphylaxis

PLoS ONE ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. e90199 ◽  
Author(s):  
Yan-Ni Mi ◽  
Na-Na Ping ◽  
Xue Xiao ◽  
Yan-Bing Zhu ◽  
Jing Liu ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Anaphylactoid Reaction ◽  
Vitamin K1 ◽  
Severe Adverse Reaction

scholarly journals Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

2018 ◽  
Vol 11 (1) ◽  
pp. 119-124 ◽  
Author(s):  
Jorine de Haan ◽  
Johannes V. van Thienen ◽  
Michael Casaer ◽  
Rebekka A. Hannivoort ◽  
Kristel Van Calsteren ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Case Report ◽  
Pregnant Woman ◽  
Metastatic Melanoma ◽  
Targeted Therapies ◽  
Adverse Reactions ◽  
Tumour Progression ◽  
Single Case ◽  
Severe Adverse Reaction ◽  
Single Case Report

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogenesis. For the BRAF V600 inhibitor vemurafenib, the available literature about the effects on human pregnancy is limited to a single case report. In patients with metastatic melanoma that wish to continue their pregnancy, targeted therapies like vemurafenib offer the only possibility of improving maternal outcome. In this article, we report on a pregnant woman with metastatic melanoma who was treated with vemurafenib during pregnancy and experienced a fatal adverse reaction.

Tocainide: A Severe Adverse Reaction

1988 ◽  
Vol 22 (2) ◽  
pp. 142-145 ◽  
Author(s):  
James M. Dunn ◽  
Paul E. Groth ◽  
Anne DeSimone
Keyword(s):  
Adverse Reaction ◽  
Short Term Memory ◽  
Memory Loss ◽  
Uneventful Recovery ◽  
Physical Status ◽  
Short Term ◽  
Severe Adverse Reaction ◽  
Premature Ventricular Contractions ◽  
Term Memory ◽  
Cardioactive Drug

Tocainide is a primary analog of lidocaine with antiarrhythmic properties used to treat ventricular rhythm disorders. A 76-year-old man with benign paroxysmal premature ventricular contractions was treated with tocainide and developed a generalized maculopapular lupoid eruption, bleeding from the lips and gingivae, vertigo, gross tremors of the extremities, fever, and short-term memory loss, which required hospitalization. The patient recovered slowly over three months with no permanent sequelae after discontinuing the drug and receiving rigorous supportive care. His excellent physical status and absence of concomitant illness contributed to an uneventful recovery. Tocainide is a potent cardioactive drug with a long biological half-life and should be used with caution.

Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation

2013 ◽  
Vol 161 (5) ◽  
pp. 430-440 ◽  
Author(s):  
Manuela G. Neuman ◽  
Kristi K. McKinney ◽  
Radu M. Nanau ◽  
Vincent Kong ◽  
Izabella Malkiewicz ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Herpes Virus ◽  
Human Herpes ◽  
Severe Adverse Reaction ◽  
Drug Induced ◽  
Human Herpes Virus ◽  
Human Herpes Virus 6 ◽  
Herpès Virus

scholarly journals Temporary Henna Tattooing: a Case of Contact Dermatitis

2016 ◽  
Vol 10 (1) ◽  
pp. 82-84
Author(s):  
Peyton E. Goodie ◽  
Craig G. Burkhart
Keyword(s):  
Adverse Reaction ◽  
Contact Dermatitis ◽  
Severe Adverse Reaction ◽  
Mild Pain

A case of a temporary henna tattoo is presented in which red henna containing p-phenylenediamine (PPD) caused a severe adverse reaction. The eruption began three days after its application and patient experienced itching and mild pain at the tattoo site along with an erythematous, papular lesion. The topic is discussed with pictures of this eruption.

Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas

1996 ◽  
Vol 12 (11) ◽  
pp. 448-450 ◽  
Author(s):  
Jean-Philippe Chippaux ◽  
Michel Boussinesq ◽  
Jacques Gardon ◽  
Nathalie Gardon-Wendel ◽  
Jean-Christophe Ernould
Keyword(s):  
Adverse Reaction ◽  
Mass Treatment ◽  
Severe Adverse Reaction ◽  
Endemic Areas
Sign in / Sign up

Export Citation Format

Share Document